Bolt Biotherapeutics, Inc. (BOLT) led the latest midday scan, gaining approximately 68.2%. The table below ranks the leading qualifying movers captured in the latest snapshot.
Top 10 Midday Movers
Scanner snapshot captured 2026-10-23T16:00:03.831Z.
| # | Ticker | Company | Move | Price | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 1 | BOLT | Bolt Biotherapeutics, Inc. | +68.2% | $7.05 | 9,346,907 | $13.6M |
| 2 | CLRO | ClearOne, Inc. | +54.3% | $2.96 | 16,668,073 | $7.9M |
| 3 | MYND | Mynd.ai, Inc. | +44.9% | $0.2359 | 44,650,128 | $7.7M |
| 4 | YMAT | J-Star Holding Co., Ltd. | +38.0% | $2.65 | 42,056,741 | $10.6M |
| 5 | GPUS | Hyperscale Data, Inc. | +35.7% | $0.1710 | 244,231,471 | $32.8M |
| 6 | BKYI | BIO-key International, Inc. | +33.6% | $3.66 | 27,288,647 | $7.4M |
| 7 | HTCO | High-Trend International Group | +32.1% | $1.54 | 1,391,720 | $14.0M |
| 8 | LUCD | Lucid Diagnostics Inc. | +25.3% | $0.4107 | 84,378,814 | $83.5M |
| 9 | ESLA | Estrella Immunopharma, Inc. | +22.0% | $0.8866 | 868,838 | $38.6M |
| 10 | AIXI | XIAO-I Corporation | +21.8% | $3.02 | 15,799,392 | $1.4M |
What’s Driving the Moves
BOLT — Bolt Biotherapeutics, Inc.
BOLT gained approximately 68.2% in the scanner snapshot. A possible catalyst was Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications. The headline should be verified against the original source before publication.
CLRO — ClearOne, Inc.
CLRO gained approximately 54.3% in the scanner snapshot. A possible catalyst was Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.. The headline should be verified against the original source before publication.
MYND — Mynd.ai, Inc.
MYND gained approximately 44.9% in the scanner snapshot. A possible catalyst was Mynd.ai Announces CEO and CFO Transition. The headline should be verified against the original source before publication.
YMAT — J-Star Holding Co., Ltd.
YMAT gained approximately 38.0% in the scanner snapshot. A possible catalyst was J-Star Holding Advances U.S. Drone Manufacturing Plans With Houston Facility Acquisition Negotiations. The headline should be verified against the original source before publication.
GPUS — Hyperscale Data, Inc.
GPUS gained approximately 35.7% in the scanner snapshot. A possible catalyst was Hyperscale Data Announces Suspension of Its At-the-Market Offering. The headline should be verified against the original source before publication.
BKYI — BIO-key International, Inc.
BKYI gained approximately 33.6% in the scanner snapshot. A possible catalyst was BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management Solutions. The headline should be verified against the original source before publication.
HTCO — High-Trend International Group
HTCO gained approximately 32.1% in the scanner snapshot. A possible catalyst was Why Is High-Trend International Stock Sinking Wednesday?. The headline should be verified against the original source before publication.
LUCD — Lucid Diagnostics Inc.
LUCD gained approximately 25.3% in the scanner snapshot. A possible catalyst was Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing. The headline should be verified against the original source before publication.
ESLA — Estrella Immunopharma, Inc.
ESLA gained approximately 22.0% in the scanner snapshot. A possible catalyst was Estrella Immunopharma Treats First Patient with Two EB103 Infusions in STARLIGHT-1 Dose-Expansion Phase. The headline should be verified against the original source before publication.
AIXI — XIAO-I Corporation
AIXI gained approximately 21.8% in the scanner snapshot. A possible catalyst was Xiao-I Corporation Announces Plan to Implement ADS Ratio Change. The headline should be verified against the original source before publication.
What To Watch Next
Premarket and after-hours moves can reverse quickly. Editors should verify the catalyst, filing history, financing activity, float structure and liquidity before publication.
